<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00720213</url>
  </required_header>
  <id_info>
    <org_study_id>MR-0731-ASV3-MS</org_study_id>
    <nct_id>NCT00720213</nct_id>
  </id_info>
  <brief_title>Evaluation of Software Enhancements to the Respironics BiPAP Auto Servo Ventilation (AutoSV) Device</brief_title>
  <acronym>AUTOSV3</acronym>
  <official_title>Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Respironics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being undertaken to collect data from Respironics Inc's BiPAP Auto Servo
      Ventilation 3 (autoSV3) and compare with data from Respironics, Inc's BiPAP autoSV2, to
      confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat
      participants experiencing Complex Sleep Apneas (Comp SAS) no worse than its predecessor, the
      BiPAP auto Servo ventilation 2 (autoSV2) device. This will be determined using a comparative,
      randomized design with the participants blinded to the therapy. Additionally, attempts will
      be made to blind the central scorer(s) with respect to which device is in use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was conducted to evaluate the therapeutic performance of a new auto Servo
      Ventilation device (Philips Respironics autoSV Advanced) for the treatment of complex central
      sleep apnea (CompSA). The features of autoSV Advanced include an automatic expiratory
      pressure (EPAP) adjustment, an advanced algorithm for distinguishing open versus obstructed
      airway apnea, a modified auto backup rate which is proportional to subject's baseline
      breathing rate, and a variable inspiratory support. Our primary aim was to compare the
      performance of the advanced servo-ventilator (BiPAP autoSV Advanced) with conventional
      servo-ventilator (BiPAP autoSV) in treating central sleep apnea (CSA).

      Study Design: A prospective, multicenter, randomized, controlled trial.

      Setting: Five sleep laboratories in the United States.

      Participants: Thirty-seven participants were included.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea Hypopnea Index</measure>
    <time_frame>2 nights</time_frame>
    <description>The number of apneas and hypopneas per hour of sleep. Apneas are the cessation of airflow at the nostrils and mouth for at least 10 seconds as determined using nasal-oral thermistor or device flow. Hypopneas is shallow breathing in which the air flow in and out of the airway is significantly reduced as detected by nasal pressure or device flow - often associated with oxygen desaturation of 4% or EEG arousal.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of apneas and hyopneas per hour. The index is the average number for apneas+hyopneas per hour.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apnea Hypopnea Index- REM and NREM</measure>
    <time_frame>2 nights</time_frame>
    <description>The number of apneas and hypopneas per hour of sleep while in REM (rapid eye movement) and in NREM (non-rapid eye movement)
A central sleep scorer was utilized to review of the overnight PSGs and count the number of apneas and hyopneas per hour while in REM vs. NREM.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Apnea Index</measure>
    <time_frame>2 nights</time_frame>
    <description>The number of central apneas divided by the number of hours of sleep. Central apneas are the cessation of airflow at the nostrils and mouth for at least 10 seconds that is associated with the absence of inspiratory effort.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of central apneas per hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstructive Apnea Index</measure>
    <time_frame>2 nights</time_frame>
    <description>Obstructive sleep apnea (OSA) is the most common type of sleep apnea and is caused by complete or partial obstructions of the upper airway.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of obstructive apneas per hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mixed Apnea Index</measure>
    <time_frame>2 nights</time_frame>
    <description>Mixed sleep apnea is a combination of both obstructive and central sleep apnea symptoms
A central sleep scorer was utilized to review of the overnight PSGs and count the number of mixed apneas per hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypopnea Index</measure>
    <time_frame>2 nights</time_frame>
    <description>Hypopneas are characterized by shallow breathing in which the air flow in and out of the airway is significantly reduced as detected by nasal pressure or device flow - often associated with oxygen desaturation of 4% or EEG arousal.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of hyopneas per hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Onset Latency</measure>
    <time_frame>2 nights</time_frame>
    <description>Sleep onset latency is the length of time that it takes to accomplish the transition from full wakefulness to sleep, normally to the lightest of the non-REM sleep stages. This found by reviewing the number of minutes in the PSG it took from lights off until the lightest non-REM sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid Eye Movement (REM) Onset Latency</measure>
    <time_frame>2 nights</time_frame>
    <description>Rapid eye movement latency is the time from the sleep onset to the first epoch of REM sleep; therefore, it depends on the patient's sleep latency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake After Sleep Onset</measure>
    <time_frame>2 nights</time_frame>
    <description>Wake after sleep onset refers to periods of wakefulness occurring after defined sleep onset. This was calculated by adding the total number of minutes the participant was awake after sleep onset.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Sleep Time</measure>
    <time_frame>2 nights</time_frame>
    <description>Total sleep time is the total time the participant was asleep after sleep onset. This is calculated by adding the total number of minutes the participant was asleep during the night after sleep onset.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency</measure>
    <time_frame>2 nights</time_frame>
    <description>Sleep efficiency is a measure of how much a participant slept over the night. This is calculated by comparing the total sleep time and the total recording time * 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stages N1,N2,N3 (NREM), and REM (R) Sleep (in Minutes)REM, NREM and Total Sleep Time.</measure>
    <time_frame>2 nights</time_frame>
    <description>These measures are the amount of time patients spent in each stage of sleep in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep (% TST)</measure>
    <time_frame>2 nights</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal Index [Total, Apnea Hypopnea (AH)-Related, Periodic Limb Movement (PLM)-Related, 'Spontaneous']</measure>
    <time_frame>2 nights</time_frame>
    <description>The number of arousals and awakenings is registered in the study, and reported as a total number and as a frequency per hour of sleep, which is referred to as an index. The higher the arousal index, the more tired you are likely to feel, though people vary in their tolerance of sleep disruptions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nocturnal Oxygenation (Measured by Continuous Pulse Oximetry During Sleep Study)</measure>
    <time_frame>2 nights</time_frame>
    <description>Measure of oxygen saturation as measured by a pulse oximetry over the course of the night.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apnea Hypopnea Index (REM, NREM and TST) Using Modified Hypopnea Rule.</measure>
    <time_frame>2 nights</time_frame>
    <description>This is the measure of the Apnea Hypopnea Index as measured by using a modified hypopnea rule. The modified hypopnea rule is a scoring change when AHI changes due to central vs obstructive apneas.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apnea Hypopnea Index(REM, NREM and TST) During Epochs for Which Leak is Determined to Exist Within Acceptable Limits.</measure>
    <time_frame>2 nights</time_frame>
    <description>The AHI during epochs for which leak is determined to exist within acceptable limits occurs is the same calculation during AHI is normally calculated just in a 30 second (epoch) time period.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Sleep Disordered Breathing</condition>
  <condition>Sleep Apnea, Central</condition>
  <arm_group>
    <arm_group_label>Respironics BiPAP autoSV2, Then Respironics BiPAP autoSV3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized to receive Respironics BiPAP autoSV2 first and Respironics BiPAP autoSV3 second.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Respironics BiPAP autoSV3, then Respironics BiPAP autoSV2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be randomized to receive Respironics BiPAP autoSV3 first and Respironics BiPAP autoSV2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respironics BiPAP autoSV2</intervention_name>
    <description>Respironics BiPAP autoSV2 is an Auto Servo Ventilation Device. This will be used on a randomized night.</description>
    <arm_group_label>Respironics BiPAP autoSV2, Then Respironics BiPAP autoSV3</arm_group_label>
    <arm_group_label>Respironics BiPAP autoSV3, then Respironics BiPAP autoSV2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respironics BiPAP autoSV3</intervention_name>
    <description>Respironics BiPAP autoSV3 is an Auto Servo Ventilation Device. This will be used on a randomized night.</description>
    <arm_group_label>Respironics BiPAP autoSV2, Then Respironics BiPAP autoSV3</arm_group_label>
    <arm_group_label>Respironics BiPAP autoSV3, then Respironics BiPAP autoSV2</arm_group_label>
    <other_name>Respironics BiPAP autoSV3 advanced</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Pre-Study Inclusion Criteria:

          -  Age 21-80

          -  Ability to provide consent

          -  Documentation of medical stability by investigator

        Enrollment Inclusion Criteria:

        • Participants who, during the ambulatory polysomnography (PSG) study (Stardust), or in lab
        Diagnostic PSG demonstrated an Apnea Hypopnea Index (AHI) ≥10 or Central Apnea Index (CAI)
        ≥5

        or

        • Participants who previously demonstrated Central sleep Apnea (CSA), with a CAI≥5 on
        Continuous Positive Airway Pressure (CPAP) titration.

        Exclusion Criteria:

          -  • Participants who are acutely ill, medically complicated or who are medically
             unstable.

               -  Pregnancy (will confirm absence of pregnancy with a urine or serum pregnancy test
                  in women of child bearing potential).

               -  Participants in whom PAP therapy is otherwise medically contraindicated.

               -  Participants who are unwilling to wear CPAP

               -  Participants who are currently prescribed nocturnal oxygen use and are unable to
                  forego oxygen during study nights.

               -  Participants with previously diagnosed respiratory failure or respiratory
                  insufficiency and who are known to have chronically elevated arterial carbon
                  dioxide levels while awake (PaCO2 ≥ 45mmHg).

               -  Participants who have had surgery of the upper airway, nose, sinus, or middle ear
                  within the previous 90 days.

               -  Participants with untreated, non- Obstructive Sleep Apnea (OSA)/CSA sleep
                  disorders, including but not limited to; insomnia, periodic limb movement
                  syndrome, or restless legs syndrome (PLM Arousal Index &gt; 15).

               -  Participants who are unwilling to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jamie Goodwin</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arizona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shahrokh Javaheri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleepcare Diagnostics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rami Khayat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State Univercity</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Goetting, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Wylie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arkansas Center for Sleep Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Center for Sleep Medicine</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mark G. Goetting</name>
      <address>
        <city>Portage</city>
        <state>Michigan</state>
        <zip>49024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sleepcare Diagnostics</name>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>July 18, 2008</study_first_submitted>
  <study_first_submitted_qc>July 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2008</study_first_posted>
  <results_first_submitted>August 11, 2010</results_first_submitted>
  <results_first_submitted_qc>January 4, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 29, 2019</results_first_posted>
  <last_update_submitted>January 4, 2019</last_update_submitted>
  <last_update_submitted_qc>January 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from the investigators' sleep labs.</recruitment_details>
      <pre_assignment_details>Participants were excluded if they did not demonstrate an Apnea-Hypopnea Index (AHI) ≥ 10 and Central Apnea Index (CAI)≥ 5 during the diagnostic polysomnography (PSG), or if they did not demonstrate a CAI ≥ 5 on continuous positive airway pressure (CPAP) titration.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Screening Phase</title>
          <description>All participants that signed a consent form.</description>
        </group>
        <group group_id="P2">
          <title>BiPap Auto SV2 Device First, BiPap Auto SV3 Device Second</title>
          <description>BiPAP auto servo ventilation (SV) 2 Device. This arm used the BiPAP AutoSV2 overnight first overnight, followed by the BiPAP auto servo ventilation (SV) 3 Device. This arm used the BiPAP AutoSV3 for the second overnight.</description>
        </group>
        <group group_id="P3">
          <title>BiPap Auto SV3 Device First, BiPap AutoSV2 Device Second</title>
          <description>BiPAP auto servo ventilation (SV) 3 Device. This arm used the BiPAP AutoSV3 for the first overnight. The second overnight participants used the BiPap Auto Servo Ventilation 2 Device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Screening Phase With Diagnostic PSG</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Screen Failure</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Treatment Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All participants who met inclusion/exclusion criteria were included in the baseline analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Participants who signed the informed consent</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.2" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Apnea Hypopnea Index</title>
        <description>The number of apneas and hypopneas per hour of sleep. Apneas are the cessation of airflow at the nostrils and mouth for at least 10 seconds as determined using nasal-oral thermistor or device flow. Hypopneas is shallow breathing in which the air flow in and out of the airway is significantly reduced as detected by nasal pressure or device flow - often associated with oxygen desaturation of 4% or EEG arousal.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of apneas and hyopneas per hour. The index is the average number for apneas+hyopneas per hour.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea Hypopnea Index</title>
          <description>The number of apneas and hypopneas per hour of sleep. Apneas are the cessation of airflow at the nostrils and mouth for at least 10 seconds as determined using nasal-oral thermistor or device flow. Hypopneas is shallow breathing in which the air flow in and out of the airway is significantly reduced as detected by nasal pressure or device flow - often associated with oxygen desaturation of 4% or EEG arousal.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of apneas and hyopneas per hour. The index is the average number for apneas+hyopneas per hour.</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.44" spread="10.3"/>
                    <measurement group_id="O2" value="6.06" spread="5.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Each participant was treated with the BiPAP autoSV2 (ASV2) and autoSV Advanced (ASV3) on two separate nights; therefore, the data were analyzed as paired samples. Depending on normality, each endpoint was analyzed with either a paired t-test or the nonparametric Wilcoxon Signed Ranks test. All comparisons were 2-sided conducted at a 5% level of significance.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0054</p_value>
            <method>Wilcoxon Signed Rank test</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>3.98</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>8.03</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.44</ci_lower_limit>
            <ci_upper_limit>6.51</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apnea Hypopnea Index- REM and NREM</title>
        <description>The number of apneas and hypopneas per hour of sleep while in REM (rapid eye movement) and in NREM (non-rapid eye movement)
A central sleep scorer was utilized to review of the overnight PSGs and count the number of apneas and hyopneas per hour while in REM vs. NREM.</description>
        <time_frame>2 nights</time_frame>
        <population>Data was not scorable for NREM.</population>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea Hypopnea Index- REM and NREM</title>
          <description>The number of apneas and hypopneas per hour of sleep while in REM (rapid eye movement) and in NREM (non-rapid eye movement)
A central sleep scorer was utilized to review of the overnight PSGs and count the number of apneas and hyopneas per hour while in REM vs. NREM.</description>
          <population>Data was not scorable for NREM.</population>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Apnea Hypopnea Index- REM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.27" spread="6.15"/>
                    <measurement group_id="O2" value="2.09" spread="3.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Apnea Hypopnea Index- NREM</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.84" spread="6.52"/>
                    <measurement group_id="O2" value="11.74" spread="11.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central Apnea Index</title>
        <description>The number of central apneas divided by the number of hours of sleep. Central apneas are the cessation of airflow at the nostrils and mouth for at least 10 seconds that is associated with the absence of inspiratory effort.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of central apneas per hour.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Central Apnea Index</title>
          <description>The number of central apneas divided by the number of hours of sleep. Central apneas are the cessation of airflow at the nostrils and mouth for at least 10 seconds that is associated with the absence of inspiratory effort.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of central apneas per hour.</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.82" spread="3.72"/>
                    <measurement group_id="O2" value="0.56" spread=".71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Obstructive Apnea Index</title>
        <description>Obstructive sleep apnea (OSA) is the most common type of sleep apnea and is caused by complete or partial obstructions of the upper airway.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of obstructive apneas per hour.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Obstructive Apnea Index</title>
          <description>Obstructive sleep apnea (OSA) is the most common type of sleep apnea and is caused by complete or partial obstructions of the upper airway.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of obstructive apneas per hour.</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.04" spread="2.35"/>
                    <measurement group_id="O2" value="1.14" spread="1.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mixed Apnea Index</title>
        <description>Mixed sleep apnea is a combination of both obstructive and central sleep apnea symptoms
A central sleep scorer was utilized to review of the overnight PSGs and count the number of mixed apneas per hour.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Mixed Apnea Index</title>
          <description>Mixed sleep apnea is a combination of both obstructive and central sleep apnea symptoms
A central sleep scorer was utilized to review of the overnight PSGs and count the number of mixed apneas per hour.</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread=".69"/>
                    <measurement group_id="O2" value="0.20" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hypopnea Index</title>
        <description>Hypopneas are characterized by shallow breathing in which the air flow in and out of the airway is significantly reduced as detected by nasal pressure or device flow - often associated with oxygen desaturation of 4% or EEG arousal.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of hyopneas per hour.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Hypopnea Index</title>
          <description>Hypopneas are characterized by shallow breathing in which the air flow in and out of the airway is significantly reduced as detected by nasal pressure or device flow - often associated with oxygen desaturation of 4% or EEG arousal.
A central sleep scorer was utilized to review of the overnight PSGs and count the number of hyopneas per hour.</description>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.11" spread="6.22"/>
                    <measurement group_id="O2" value="4.16" spread="4.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Onset Latency</title>
        <description>Sleep onset latency is the length of time that it takes to accomplish the transition from full wakefulness to sleep, normally to the lightest of the non-REM sleep stages. This found by reviewing the number of minutes in the PSG it took from lights off until the lightest non-REM sleep.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Onset Latency</title>
          <description>Sleep onset latency is the length of time that it takes to accomplish the transition from full wakefulness to sleep, normally to the lightest of the non-REM sleep stages. This found by reviewing the number of minutes in the PSG it took from lights off until the lightest non-REM sleep.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.91" spread="18.53"/>
                    <measurement group_id="O2" value="20.91" spread="16.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rapid Eye Movement (REM) Onset Latency</title>
        <description>Rapid eye movement latency is the time from the sleep onset to the first epoch of REM sleep; therefore, it depends on the patient's sleep latency.</description>
        <time_frame>2 nights</time_frame>
        <population>This data was not part of the scoring PSG criteria and therefore not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Rapid Eye Movement (REM) Onset Latency</title>
          <description>Rapid eye movement latency is the time from the sleep onset to the first epoch of REM sleep; therefore, it depends on the patient's sleep latency.</description>
          <population>This data was not part of the scoring PSG criteria and therefore not collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wake After Sleep Onset</title>
        <description>Wake after sleep onset refers to periods of wakefulness occurring after defined sleep onset. This was calculated by adding the total number of minutes the participant was awake after sleep onset.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Wake After Sleep Onset</title>
          <description>Wake after sleep onset refers to periods of wakefulness occurring after defined sleep onset. This was calculated by adding the total number of minutes the participant was awake after sleep onset.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.67" spread="52.33"/>
                    <measurement group_id="O2" value="93.47" spread="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Sleep Time</title>
        <description>Total sleep time is the total time the participant was asleep after sleep onset. This is calculated by adding the total number of minutes the participant was asleep during the night after sleep onset.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Total Sleep Time</title>
          <description>Total sleep time is the total time the participant was asleep after sleep onset. This is calculated by adding the total number of minutes the participant was asleep during the night after sleep onset.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="361.23" spread="72.55"/>
                    <measurement group_id="O2" value="370.59" spread="61.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleep Efficiency</title>
        <description>Sleep efficiency is a measure of how much a participant slept over the night. This is calculated by comparing the total sleep time and the total recording time * 100.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Efficiency</title>
          <description>Sleep efficiency is a measure of how much a participant slept over the night. This is calculated by comparing the total sleep time and the total recording time * 100.</description>
          <units>percentage efficiency</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.84" spread="13.39"/>
                    <measurement group_id="O2" value="76.46" spread="11.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stages N1,N2,N3 (NREM), and REM (R) Sleep (in Minutes)REM, NREM and Total Sleep Time.</title>
        <description>These measures are the amount of time patients spent in each stage of sleep in minutes.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Stages N1,N2,N3 (NREM), and REM (R) Sleep (in Minutes)REM, NREM and Total Sleep Time.</title>
          <description>These measures are the amount of time patients spent in each stage of sleep in minutes.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Stage 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.72" spread="11.79"/>
                    <measurement group_id="O2" value="16.02" spread="9.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.54" spread="11.62"/>
                    <measurement group_id="O2" value="55.06" spread="11.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.25" spread="9.81"/>
                    <measurement group_id="O2" value="11.75" spread="10.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>REM</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" spread="6.35"/>
                    <measurement group_id="O2" value="17.18" spread="7.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TST</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="361.23" spread="72.55"/>
                    <measurement group_id="O2" value="370.59" spread="61.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep (% TST)</title>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Wake (W), Stages N1,N2,N3 (NREM), and REM (R) Sleep (% TST)</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Stage 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.72" spread="11.79"/>
                    <measurement group_id="O2" value="16.02" spread="9.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.54" spread="11.62"/>
                    <measurement group_id="O2" value="55.06" spread="11.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stage 3 &amp; 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.25" spread="9.81"/>
                    <measurement group_id="O2" value="11.75" spread="10.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>REM</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.50" spread="6.35"/>
                    <measurement group_id="O2" value="17.18" spread="7.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arousal Index [Total, Apnea Hypopnea (AH)-Related, Periodic Limb Movement (PLM)-Related, 'Spontaneous']</title>
        <description>The number of arousals and awakenings is registered in the study, and reported as a total number and as a frequency per hour of sleep, which is referred to as an index. The higher the arousal index, the more tired you are likely to feel, though people vary in their tolerance of sleep disruptions.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Arousal Index [Total, Apnea Hypopnea (AH)-Related, Periodic Limb Movement (PLM)-Related, 'Spontaneous']</title>
          <description>The number of arousals and awakenings is registered in the study, and reported as a total number and as a frequency per hour of sleep, which is referred to as an index. The higher the arousal index, the more tired you are likely to feel, though people vary in their tolerance of sleep disruptions.</description>
          <units>events per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.04" spread="11.11"/>
                    <measurement group_id="O2" value="23.58" spread="10.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nocturnal Oxygenation (Measured by Continuous Pulse Oximetry During Sleep Study)</title>
        <description>Measure of oxygen saturation as measured by a pulse oximetry over the course of the night.</description>
        <time_frame>2 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Group 1</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group 2</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Nocturnal Oxygenation (Measured by Continuous Pulse Oximetry During Sleep Study)</title>
          <description>Measure of oxygen saturation as measured by a pulse oximetry over the course of the night.</description>
          <units>percentage of oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Nocturnal oxygenation (%)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.78" spread="1.18"/>
                    <measurement group_id="O2" value="95.7" spread="1.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lowest Nocturnal oxygenation (%)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.54" spread="8.74"/>
                    <measurement group_id="O2" value="87.84" spread="4.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apnea Hypopnea Index (REM, NREM and TST) Using Modified Hypopnea Rule.</title>
        <description>This is the measure of the Apnea Hypopnea Index as measured by using a modified hypopnea rule. The modified hypopnea rule is a scoring change when AHI changes due to central vs obstructive apneas.</description>
        <time_frame>2 nights</time_frame>
        <population>During scoring of the PSG the modified hypopnea rule wasn't utlized therefore this data is not provided.</population>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea Hypopnea Index (REM, NREM and TST) Using Modified Hypopnea Rule.</title>
          <description>This is the measure of the Apnea Hypopnea Index as measured by using a modified hypopnea rule. The modified hypopnea rule is a scoring change when AHI changes due to central vs obstructive apneas.</description>
          <population>During scoring of the PSG the modified hypopnea rule wasn't utlized therefore this data is not provided.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apnea Hypopnea Index(REM, NREM and TST) During Epochs for Which Leak is Determined to Exist Within Acceptable Limits.</title>
        <description>The AHI during epochs for which leak is determined to exist within acceptable limits occurs is the same calculation during AHI is normally calculated just in a 30 second (epoch) time period.</description>
        <time_frame>2 nights</time_frame>
        <population>This was not part of the standard scoring of the PSG, therefore this was not calculated</population>
        <group_list>
          <group group_id="O1">
            <title>Respironics BiPAP autoSV2</title>
            <description>Respironics BiPAP autoSV2</description>
          </group>
          <group group_id="O2">
            <title>Respironics BiPAP autoSV3</title>
            <description>Respironics BiPAP autoSV3</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea Hypopnea Index(REM, NREM and TST) During Epochs for Which Leak is Determined to Exist Within Acceptable Limits.</title>
          <description>The AHI during epochs for which leak is determined to exist within acceptable limits occurs is the same calculation during AHI is normally calculated just in a 30 second (epoch) time period.</description>
          <population>This was not part of the standard scoring of the PSG, therefore this was not calculated</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Group 1</title>
          <description>BiPAP autoSV2 Device</description>
        </group>
        <group group_id="E2">
          <title>Treatment Group 2</title>
          <description>BiPAP autoSV3 Device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Not all of the secondary analysis was completed as this study also captured engineering data which is not part of standard PSG scoring.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Shahrokh Javaheri, MD</name_or_title>
      <organization>Sleepcare Diagnostics</organization>
      <phone>513-459-7750</phone>
      <email>javaheri@snorenomore.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

